These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11548385)

  • 61. Anti-HIV agents. Some researchers call for early HIV therapy.
    TreatmentUpdate; 2007 Jan; 19(1):1-2. PubMed ID: 17390476
    [No Abstract]   [Full Text] [Related]  

  • 62. Strategies of HIV management--when to start.
    Youle M
    AIDS; 2002; 16 Suppl 4():S145-9. PubMed ID: 12699011
    [No Abstract]   [Full Text] [Related]  

  • 63. The START Trial: Definitive Evidence to Treat All HIV-Positive Persons Regardless of CD4 Counts.
    Tabernilla A; Poveda E
    AIDS Rev; 2015; 17(3):187. PubMed ID: 26450809
    [No Abstract]   [Full Text] [Related]  

  • 64. [European guidelines with 350 CD4 cells/microliter as the magic borderline. "Euro" also in HIV therapy].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():77-8. PubMed ID: 12043083
    [No Abstract]   [Full Text] [Related]  

  • 65. Time to get SMART.
    Res Initiat Treat Action; 2001; 7(1):22-4. PubMed ID: 11548384
    [No Abstract]   [Full Text] [Related]  

  • 66. [Daily routine in an HIV specialty practice. Ambulatory patient monitoring. Interview by Waldtraut Paukstadt].
    Gölz J
    MMW Fortschr Med; 2000; 142(3 Suppl):27. PubMed ID: 10893959
    [No Abstract]   [Full Text] [Related]  

  • 67. Can the SMART study data be used to assess risk factors for renal disease?
    Gupta SK
    Ann Intern Med; 2009 Feb; 150(4):282; author reply 282-3. PubMed ID: 19221385
    [No Abstract]   [Full Text] [Related]  

  • 68. Cobicistat (Tybost) combinations for HIV.
    Med Lett Drugs Ther; 2015 Nov; 57(1482):159-60. PubMed ID: 26583606
    [No Abstract]   [Full Text] [Related]  

  • 69. Early treatment of HIV-1 infection.
    Fauci A; Bartlett JG; Goosby E
    Lancet; 1998 Dec; 352(9144):1935; author reply 1936. PubMed ID: 9863813
    [No Abstract]   [Full Text] [Related]  

  • 70. Ferrovir: a new antiviral drug for the treatment of HIV.
    Nossik D; Kaplina E; Nossik N; Sato S; Fomin Y; Voronin E
    Am Clin Lab; 2001; 20(9):36-8. PubMed ID: 11766418
    [No Abstract]   [Full Text] [Related]  

  • 71. Anti-HIV agents. New evidence changes guidelines about when to start treatment.
    TreatmentUpdate; 2009 Jan; 21(1):2-4. PubMed ID: 19248282
    [No Abstract]   [Full Text] [Related]  

  • 72. SMART starts!
    GMHC Treat Issues; 2002 Jan; 16(1):12. PubMed ID: 11871248
    [No Abstract]   [Full Text] [Related]  

  • 73. Therapies. Confronting the limits of success.
    Cohen J
    Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
    [No Abstract]   [Full Text] [Related]  

  • 74. Interleukin-2: trials and tribulations.
    Kuritzkes DR
    J Infect Dis; 2009 Jul; 200(2):164-5. PubMed ID: 19508158
    [No Abstract]   [Full Text] [Related]  

  • 75. Too smart for our own good.
    Barr D
    Res Initiat Treat Action; 2001; 7(1):25-7. PubMed ID: 11548385
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.